Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Biomolecules
2022 Nov 23;1212:. doi: 10.3390/biom12121738.
Show Gene links
Show Anatomy links
Histological and Immunohistochemical Analysis of the Effects of Topical Melatonin Treatment Associated with Collagen Sponge and rhBMP-2 Protein on Bone Remodeling.
Montarele LF
,
Pitol DL
,
Pereira BF
,
Feldman S
,
Fazan VPS
,
Issa JPM
.
Abstract
Extensive bone defect healing is an important health issue not yet completely resolved. Different alternative treatments have been proposed but, in face of a critical bone defect, it is still very difficult to reach a complete regeneration, with the new-formed bone presenting all morphological and physiological characteristics of a normal, preinjury bone. Topical melatonin use has shown as a promising adjuvant for bone regeneration due to its positive effects on bone metabolism. Thus, to search for new, safe, biological techniques that promote bone repair and favor defect healing, we hypothesized that there is a synergistic effect of melatonin treatment associated with rhBMP-2 to guide bone regeneration. This study aimed to investigate bone repair effects of topical melatonin administration in different concentrations (1, 10, and 100 µg), associated or not with rhBMP-2. Surgical-induced bone defect healing was qualitatively evaluated through histopathological analysis by light microscopy. Additionally, quantitative stereology was performed in immunohistochemistry-prepared tissue to identify angiogenic, osteogenic, and osteoclastogenic factors. Quantification data were compared between groups by the ANOVA/Tukey test and differences were considered significant when p < 0.05. Our results showed that the presence of the scaffold in the bone defect hindered the process of bone repair because in the group treated with "blood clot + scaffold" the results of bone formation and immunolabeling were reduced in comparison with all other groups (treated with melatonin alone or in association with rhBMP-2). Statistical analysis revealed a significant difference between the control group (bone defect + blood clot), and groups treated with different concentrations of melatonin in association with rhBMP-2, indicating a positive effect of the association for bone repair. This treatment is promising once it becomes a new safe alternative technique for the clinical treatment of fractures, bone defects, and bone grafts. Our results support the hypothesis of the safe use of the association of melatonin and rhBMP-2 and have established a safe and effective dose for this experimental treatment.
Basaloglu,
The influence of functional pinealectomy and exogenous melatonin application on healing of a burr hole in adult rat calvaria: a histological and immunohistochemical study.
2022, Pubmed
Basaloglu,
The influence of functional pinealectomy and exogenous melatonin application on healing of a burr hole in adult rat calvaria: a histological and immunohistochemical study.
2022,
Pubmed
Boden,
The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report.
2000,
Pubmed
Burg,
Biomaterial developments for bone tissue engineering.
2000,
Pubmed
Burkus,
Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2.
2009,
Pubmed
Carlevaro,
Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation.
2000,
Pubmed
Chen,
Melatonin restores the osteoporosis-impaired osteogenic potential of bone marrow mesenchymal stem cells by preserving SIRT1-mediated intracellular antioxidant properties.
2020,
Pubmed
Coates,
Bone turnover markers.
2013,
Pubmed
Conti,
Evidence for melatonin synthesis in mouse and human bone marrow cells.
2000,
Pubmed
Croteau,
Bone morphogenetic proteins in orthopedics: from basic science to clinical practice.
1999,
Pubmed
Cutando,
Local application of melatonin into alveolar sockets of beagle dogs reduces tooth removal-induced oxidative stress.
2007,
Pubmed
Cutando,
Melatonin stimulates osteointegration of dental implants.
2008,
Pubmed
Elgali,
Guided bone regeneration: materials and biological mechanisms revisited.
2017,
Pubmed
Gonzaga,
Effectiveness of rhBMP-2 association to autogenous, allogeneic, and heterologous bone grafts.
2019,
Pubmed
Greenspan,
Diurnal variation of bone mineral turnover in elderly men and women.
1997,
Pubmed
Grgurevic,
Autologous blood coagulum containing rhBMP6 induces new bone formation to promote anterior lumbar interbody fusion (ALIF) and posterolateral lumbar fusion (PLF) of spine in sheep.
2020,
Pubmed
Gruber,
Cell-to-cell communication in guided bone regeneration: molecular and cellular mechanisms.
2017,
Pubmed
Gómez-Moreno,
Outcomes of topical applications of melatonin in implant dentistry: a systematic review.
2015,
Pubmed
Haas,
Freeze-dried homogeneous and heterogeneous bone for sinus augmentation in sheep. Part I: histological findings.
2002,
Pubmed
Hankenson,
Biological perspectives of delayed fracture healing.
2014,
Pubmed
Hardeland,
Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling.
2012,
Pubmed
Hollinger,
The critical size defect as an experimental model to test bone repair materials.
1990,
Pubmed
Issa,
Evaluation of rhBMP-2 and natural latex as potential osteogenic proteins in critical size defects by histomorphometric methods.
2010,
Pubmed
Issa,
Bone repair of critical size defects treated with autogenic, allogenic, or xenogenic bone grafts alone or in combination with rhBMP-2.
2016,
Pubmed
Jung,
Effect of rhBMP-2 on guided bone regeneration in humans.
2003,
Pubmed
Kesemenli,
The role of melatonin as a link between head injury and enhanced osteogenesis.
2005,
Pubmed
Koyama,
Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.
2002,
Pubmed
Lei,
The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma.
2009,
Pubmed
Li,
Bone consolidation is enhanced by rhBMP-2 in a rabbit model of distraction osteogenesis.
2002,
Pubmed
Lima,
Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats.
1998,
Pubmed
Liu,
Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases.
2021,
Pubmed
Mediero,
Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2.
2015,
Pubmed
Nakade,
Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro.
1999,
Pubmed
Ostrowska,
Influence of lighting conditions on daily rhythm of bone metabolism in rats and possible involvement of melatonin and other hormones in this process.
2003,
Pubmed
Pandi-Perumal,
Melatonin: Nature's most versatile biological signal?
2006,
Pubmed
Park,
Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways.
2011,
Pubmed
Polo-Corrales,
Scaffold design for bone regeneration.
2014,
Pubmed
Ramírez-Fernández,
Melatonin promotes angiogenesis during repair of bone defects: a radiological and histomorphometric study in rabbit tibiae.
2013,
Pubmed
Ripamonti,
Periodontal regeneration: potential role of bone morphogenetic proteins.
1994,
Pubmed
Roth,
Melatonin promotes osteoblast differentiation and bone formation.
1999,
Pubmed
Sampath,
Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation.
1981,
Pubmed
Satomura,
Melatonin at pharmacological doses enhances human osteoblastic differentiation in vitro and promotes mouse cortical bone formation in vivo.
2007,
Pubmed
Schenk,
Healing pattern of bone regeneration in membrane-protected defects: a histologic study in the canine mandible.
1994,
Pubmed
Schindeler,
Bone remodeling during fracture repair: The cellular picture.
2008,
Pubmed
Schorn,
Vertical bone regeneration using rhBMP-2 and VEGF.
2017,
Pubmed
Shino,
Melatonin enhances vertical bone augmentation in rat calvaria secluded spaces.
2016,
Pubmed
Siéssere,
Application of low-level laser irradiation (LLLI) and rhBMP-2 in critical bone defect of ovariectomized rats: histomorphometric evaluation.
2011,
Pubmed
Street,
Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover.
2002,
Pubmed
Talwar,
Effects of carrier release kinetics on bone morphogenetic protein-2-induced periodontal regeneration in vivo.
2001,
Pubmed
Toriumi,
Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation.
1991,
Pubmed
Turri,
Guided bone regeneration is promoted by the molecular events in the membrane compartment.
2016,
Pubmed
Urban,
Guided Bone Regeneration in Alveolar Bone Reconstruction.
2019,
Pubmed
Wang,
Recombinant human bone morphogenetic protein induces bone formation.
1990,
Pubmed
Wikesjö,
Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
2008,
Pubmed
Wikesjö,
rhBMP-2 significantly enhances guided bone regeneration.
2004,
Pubmed
Wozney,
Novel regulators of bone formation: molecular clones and activities.
1988,
Pubmed
Zawilska,
Physiology and pharmacology of melatonin in relation to biological rhythms.
2009,
Pubmed
Zhang,
Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression.
2010,
Pubmed
dos S Kotake,
Bone Recuperation After rhBMP-2 Insertion in Alcoholic Animals-Experimental Study.
2015,
Pubmed
